SEATTLE — OpenAI and Amazon have signed a $38 billion deal that enables the ChatGPT maker to run its artificial intelligence systems on Amazon’s cloud computing services.
OpenAI will get access to “hundreds of thousands” of Nvidia’s specialized AI chips through Amazon Web Services as part of the deal announced Monday.
The agreement comes less than a week after OpenAI altered its partnership with its longtime backer Microsoft, which is no longer the startup’s exclusive cloud provider.
California and Delaware regulators also last week allowed OpenAI, which was founded as a nonprofit, to move forward on its plan to form a new business structure to more easily raise capital and make a profit.
“The rapid advancement of AI technology has created unprecedented demand for computing power,” Amazon said in a statement Monday. It said OpenAI “will immediately start utilizing AWS compute as part of this partnership, with all capacity targeted to be deployed before the end of 2026, and the ability to expand further into 2027 and beyond.”
Related Posts:
- OpenAI and Amazon sign $38 billion deal for AI computing power News SEATTLE — OpenAI and Amazon have signed a $38 billion deal that enables the ChatGPT maker to run its artificial intelligence systems on Amazon’s cloud computing services. OpenAI will get access to “hundreds of thousands” of Nvidia’s specialized AI chips through Amazon Web Services as part of the deal announced…
- OpenAI and Amazon sign $38 billion deal for AI computing power News SEATTLE — OpenAI and Amazon have signed a $38 billion deal that enables the ChatGPT maker to run its artificial intelligence systems on Amazon’s cloud computing services. OpenAI will get access to “hundreds of thousands” of Nvidia’s specialized AI chips through Amazon Web Services as part of the deal announced…
- Tylenol, Kleenex, Band-Aid and more put under one roof in $48.7 billion consumer brands deal News By MICHELLE CHAPMAN, Associated Press Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of the combined company. Kenvue shareholders will own about 46% in what is one of…
- Tylenol, Kleenex, Band-Aid and more put under one roof in $48.7 billion consumer brands deal News By MICHELLE CHAPMAN, Associated Press Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of the combined company. Kenvue shareholders will own about 46% in what is one of…
- Blue Jays Ace Predicted to Sign New $75 Million Deal Sports The Toronto Blue Jays lost Game 7 of the World Series in heart-wrenching fashion. Despite owning a 4-3 lead over the Los Angeles Dodgers, the reigning champions were able to mount a comeback, resulting in a 5-4 victory. With the help of a Will Smith home run and a double…
(Visited 1 times, 1 visits today)